Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muaiad Kittaneh

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Breast Cancer : Basic and Clinical Research|November 16, 2011
Exemestane in the adjuvant treatment of breast cancer in postmenopausal womenMuaiad Kittaneh, Stefan Glück
Journal of Translational Medicine|July 14, 2018
Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family membersMuaiad Kittaneh, Charles Berkelhammer
BMC Cancer|March 29, 2017
Malignant acrospiroma: a case report in the era of next generation sequencingMaria Diab, Ali Gabali, Muaiad Kittaneh
Biomarkers in Cancer|November 20, 2013
Molecular profiling for breast cancer: a comprehensive reviewMuaiad Kittaneh, Alberto J Montero, Stefan Glück
Translational Lung Cancer Research|March 25, 2020
BAP1: role in carcinogenesis and clinical implicationsDaniel A Kobrinski, Haining Yang, Muaiad Kittaneh
Case Reports in Oncological Medicine|July 16, 2020
Malignant Gastrointestinal Neuroectodermal Tumor (GNET) with Prolonged Disease-Free Survival after Platinum-Based ChemotherapyDaulath Singh, Mohammed K Atieh, Mark A Russell, et al.
Case Reports in Hepatology|June 14, 2016
Antihistamine-Induced Hepatitis: 2 Cases Involving LoratidineHafiz Arshad, Arsalan Khan, Usama Assad, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 22, 2025
An overview of BAP1 biological functions and current therapeuticsAbdelrahman M Elsayed, Muaiad Kittaneh, Colleen M Cebulla, et al.
Clinical Breast Cancer|March 30, 2021
Advances in Therapeutic Approaches for Triple-Negative Breast CancerReshma Mahtani, Muaiad Kittaneh, Kevin Kalinsky, et al.
Breast Cancer Research and Treatment|May 5, 2018
Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)Jame Abraham, Robert Coleman, Anthony Elias, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Breast Cancer : Basic and Clinical Research|November 16, 2011
Exemestane in the adjuvant treatment of breast cancer in postmenopausal womenMuaiad Kittaneh, Stefan Glück
Journal of Translational Medicine|July 14, 2018
Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family membersMuaiad Kittaneh, Charles Berkelhammer
BMC Cancer|March 29, 2017
Malignant acrospiroma: a case report in the era of next generation sequencingMaria Diab, Ali Gabali, Muaiad Kittaneh
Biomarkers in Cancer|November 20, 2013
Molecular profiling for breast cancer: a comprehensive reviewMuaiad Kittaneh, Alberto J Montero, Stefan Glück
Translational Lung Cancer Research|March 25, 2020
BAP1: role in carcinogenesis and clinical implicationsDaniel A Kobrinski, Haining Yang, Muaiad Kittaneh
Case Reports in Oncological Medicine|July 16, 2020
Malignant Gastrointestinal Neuroectodermal Tumor (GNET) with Prolonged Disease-Free Survival after Platinum-Based ChemotherapyDaulath Singh, Mohammed K Atieh, Mark A Russell, et al.
Case Reports in Hepatology|June 14, 2016
Antihistamine-Induced Hepatitis: 2 Cases Involving LoratidineHafiz Arshad, Arsalan Khan, Usama Assad, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 22, 2025
An overview of BAP1 biological functions and current therapeuticsAbdelrahman M Elsayed, Muaiad Kittaneh, Colleen M Cebulla, et al.
Clinical Breast Cancer|March 30, 2021
Advances in Therapeutic Approaches for Triple-Negative Breast CancerReshma Mahtani, Muaiad Kittaneh, Kevin Kalinsky, et al.
Breast Cancer Research and Treatment|May 5, 2018
Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)Jame Abraham, Robert Coleman, Anthony Elias, et al.
Pageof 2